ES520226A0 - Procedimiento para la preparacion de derivados de cefem. - Google Patents

Procedimiento para la preparacion de derivados de cefem.

Info

Publication number
ES520226A0
ES520226A0 ES520226A ES520226A ES520226A0 ES 520226 A0 ES520226 A0 ES 520226A0 ES 520226 A ES520226 A ES 520226A ES 520226 A ES520226 A ES 520226A ES 520226 A0 ES520226 A0 ES 520226A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
compounds
bacterial infections
cefem derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES520226A
Other languages
English (en)
Other versions
ES8401492A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8401492A1 publication Critical patent/ES8401492A1/es
Publication of ES520226A0 publication Critical patent/ES520226A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Rigid Pipes And Flexible Pipes (AREA)
ES520226A 1982-03-04 1983-03-02 Procedimiento para la preparacion de derivados de cefem. Granted ES520226A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823207840 DE3207840A1 (de) 1982-03-04 1982-03-04 "cephalosporinderivate und verfahren zu ihrer herstellung"

Publications (2)

Publication Number Publication Date
ES8401492A1 ES8401492A1 (es) 1983-12-01
ES520226A0 true ES520226A0 (es) 1983-12-01

Family

ID=6157330

Family Applications (1)

Application Number Title Priority Date Filing Date
ES520226A Granted ES520226A0 (es) 1982-03-04 1983-03-02 Procedimiento para la preparacion de derivados de cefem.

Country Status (21)

Country Link
US (1) US4647556A (es)
EP (1) EP0088320B1 (es)
JP (1) JPS58162592A (es)
KR (1) KR840004117A (es)
AT (1) ATE39696T1 (es)
AU (1) AU565927B2 (es)
CA (1) CA1219857A (es)
DE (2) DE3207840A1 (es)
DK (1) DK108183A (es)
ES (1) ES520226A0 (es)
FI (1) FI830704L (es)
GR (1) GR77915B (es)
HU (1) HU190442B (es)
IL (1) IL68026A0 (es)
MA (1) MA19736A1 (es)
MT (1) MTP925B (es)
NO (1) NO830729L (es)
NZ (1) NZ203436A (es)
OA (1) OA07335A (es)
PT (1) PT76336B (es)
ZA (1) ZA831452B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76701B (es) * 1981-09-08 1984-08-29 Lilly Co Eli
US4690921A (en) * 1983-10-11 1987-09-01 Yamanouchi Pharmaceutical Co., Ltd. Cephalosporin compounds and salts thereof
EP0138552A3 (en) * 1983-10-17 1986-03-19 Eli Lilly And Company Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins
JPS6094984A (ja) * 1983-10-28 1985-05-28 Dai Ichi Seiyaku Co Ltd セフエム誘導体
EP0150507B1 (en) * 1983-12-29 1992-08-05 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives, processes for producing the same and compositions containing them
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
EP0150609A3 (en) * 1983-12-30 1986-04-23 Glaxo Group Limited Cephalosporin antibiotics
EP0148004A3 (en) * 1983-12-30 1986-04-23 Glaxo Group Limited Cephalosporin antibiotics
JPS60169486A (ja) * 1984-02-10 1985-09-02 Yamanouchi Pharmaceut Co Ltd ７−アミノ−３−置換メチル−３−セフエム−４−カルボン酸およびその低級アルキルシリル誘導体の製造法
DE3404906A1 (de) * 1984-02-11 1985-08-14 Bayer Ag, 5090 Leverkusen 1-oxadethiacephalosporinderivate sowie verfahren zu ihrer herstellung
JPS60222490A (ja) * 1984-04-17 1985-11-07 Dai Ichi Seiyaku Co Ltd セフアロスポリン誘導体およびその塩
EP0160546A3 (en) * 1984-04-26 1986-12-17 Yamanouchi Pharmaceutical Co. Ltd. Cephalosporin compounds, and their production, and medicaments containing them
EP0182633A3 (en) * 1984-11-20 1987-09-02 Ici Pharma Cephalosporin derivatives
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
GB8626245D0 (en) * 1985-11-27 1986-12-03 Ici Pharma Cephalosporin compounds
US5147871A (en) * 1986-07-03 1992-09-15 Hoffmann La-Roche, Inc. Anti-bacterial cephalosporin compounds
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US5162523A (en) * 1989-07-21 1992-11-10 Hoffmann-La Roche Inc. Cephalosporin antibacterial compounds
US5159077A (en) * 1989-07-21 1992-10-27 Hoffmann-La Roche Inc. Penam antibacterial compounds
US6214818B1 (en) * 1996-04-04 2001-04-10 Shionogi & Co., Ltd. Cephem compounds and pharmaceutical compositions containing the same
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
RS55365B1 (sr) 2008-10-31 2017-03-31 Shionogi & Co Cefalosporin sa kateholskom grupom
CN102918048A (zh) 2010-04-05 2013-02-06 盐野义制药株式会社 具有儿茶酚基团的头孢烯类化合物
WO2011136268A1 (ja) 2010-04-28 2011-11-03 塩野義製薬株式会社 新規なセフェム誘導体
US20130065874A1 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US9290515B2 (en) 2011-10-04 2016-03-22 Shionogi & Co., Ltd Cephem derivative having catechol group
TWI547496B (zh) * 2011-10-04 2016-09-01 葛蘭素集團公司 抗菌化合物
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140274996A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Tazobactam and ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4970990A (es) * 1973-09-29 1974-07-09
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
JPS5919553B2 (ja) * 1976-01-01 1984-05-07 武田薬品工業株式会社 セフアロスポリン
US4440766A (en) * 1976-03-09 1984-04-03 Fujisawa Pharmaceutical Co., Ltd. 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
GB1591439A (en) * 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
KR830000606B1 (ko) * 1978-05-26 1983-03-17 헤롤드 월터 마틴 세팔로스포린 항생제의 제조방법
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4237168A (en) * 1979-06-11 1980-12-02 The Dow Chemical Company N-(4-Chloro-2-methylphenyl)-N-hydroxy methanimidamide and its pesticidal use
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
JPS56131592A (en) * 1980-03-18 1981-10-15 Bristol Mayers Kenkyusho Kk Antimicrobial agent
ZA813787B (en) * 1980-06-18 1982-07-28 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
FR2485540A1 (fr) * 1980-06-30 1981-12-31 Sanofi Sa Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
ZA826538B (en) * 1981-09-08 1984-04-25 Lilly Co Eli Thieno and furopyridinium-substituted cephalosporin derivatives
US4396620A (en) * 1981-09-08 1983-08-02 Eli Lilly And Company Cephalosporin quinolinium betaines
US4396619A (en) * 1981-09-08 1983-08-02 Eli Lilly And Company Cephalosporin betaines
JPS5859991A (ja) * 1981-09-14 1983-04-09 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物
US4501739A (en) * 1982-01-19 1985-02-26 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporins

Also Published As

Publication number Publication date
JPS58162592A (ja) 1983-09-27
MA19736A1 (fr) 1983-10-01
US4647556A (en) 1987-03-03
NO830729L (no) 1983-09-05
FI830704A0 (fi) 1983-03-02
KR840004117A (ko) 1984-10-06
MTP925B (en) 1984-02-13
NZ203436A (en) 1986-06-11
ES8401492A1 (es) 1983-12-01
EP0088320B1 (de) 1989-01-04
ATE39696T1 (de) 1989-01-15
FI830704L (fi) 1983-09-05
AU1203983A (en) 1983-09-08
DE3207840A1 (de) 1983-09-15
CA1219857A (en) 1987-03-31
GR77915B (es) 1984-09-25
PT76336A (de) 1983-04-01
PT76336B (de) 1985-12-13
ZA831452B (en) 1983-11-30
AU565927B2 (en) 1987-10-01
EP0088320A2 (de) 1983-09-14
IL68026A0 (en) 1983-06-15
DK108183A (da) 1983-09-05
OA07335A (fr) 1984-08-31
DE3378827D1 (en) 1989-02-09
HU190442B (en) 1986-09-29
DK108183D0 (da) 1983-03-03
EP0088320A3 (en) 1986-03-19

Similar Documents

Publication Publication Date Title
ES520226A0 (es) Procedimiento para la preparacion de derivados de cefem.
ES499485A0 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
SE8306994D0 (sv) Cefemderivat och forfarande for deras framstellning
ES521086A0 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ES2136591T3 (es) Derivados de cefalosporina y procedimiento para su preparacion.
ES521082A0 (es) Procedimiento para la preparacion de derivados de acido salicilico.
ES525441A0 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
NO823682L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridazinonimin-derivater.
ES509154A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.